Chandra Bhagat Pharma (542934) Stock Overview
Engages in the marketing of pharmaceutical critical care and health care products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
542934 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Chandra Bhagat Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹40.50 |
| 52 Week High | ₹73.00 |
| 52 Week Low | ₹33.00 |
| Beta | -0.80 |
| 1 Month Change | -10.00% |
| 3 Month Change | -1.51% |
| 1 Year Change | -40.44% |
| 3 Year Change | -66.19% |
| 5 Year Change | -5.81% |
| Change since IPO | -21.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542934 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 3.3% | -4.8% | -3.1% |
| 1Y | -40.4% | 4.2% | 2.6% |
Return vs Industry: 542934 underperformed the Indian Healthcare industry which returned 4.2% over the past year.
Return vs Market: 542934 underperformed the Indian Market which returned 2.6% over the past year.
Price Volatility
| 542934 volatility | |
|---|---|
| 542934 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.2% |
Stable Share Price: 542934's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine 542934's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 40 | Hemant Bhagat | www.cbcpharma.com |
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its own brand. The company also promotes and markets specialty chemicals, as well as intermediates and active pharmaceuticals ingredients.
Chandra Bhagat Pharma Limited Fundamentals Summary
| 542934 fundamental statistics | |
|---|---|
| Market cap | ₹309.35m |
| Earnings (TTM) | ₹6.22m |
| Revenue (TTM) | ₹493.95m |
Is 542934 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542934 income statement (TTM) | |
|---|---|
| Revenue | ₹493.95m |
| Cost of Revenue | ₹357.35m |
| Gross Profit | ₹136.59m |
| Other Expenses | ₹130.37m |
| Earnings | ₹6.22m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 27.65% |
| Net Profit Margin | 1.26% |
| Debt/Equity Ratio | 69.4% |
How did 542934 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/22 11:32 |
| End of Day Share Price | 2026/01/22 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chandra Bhagat Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.